Subramanian, S., Rajendiran, M., Paramasivam, M., Murugesan, I., Palani, S. and Velusamy, S. 2026. Advances in SGLT2 Inhibitor Therapy: Comparative Evidence for Empagliflozin and Dapagliflozin in Cardio-Renal-Metabolic Disorders. International Journal of Advancement in Life Sciences Research. 9, 4 (Oct. 2026), 56-68. DOI:https://doi.org/https://doi.org/10.31632/ijalsr.2026.v09i04.004.